EQS-News: QUANTRO Therapeutics GmbH: QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments
EQS-News: QUANTRO Therapeutics GmbH / Key word(s): Miscellaneous QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class